Plasminogen activator inhibitor-1 4G allele in the 4G/5G promoter polymorphism increases the occurrence of cerebral ischemia after aneurysmal subarachnoid hemorrhage

Stroke

Volumn 35, Issue 6, 2004, Pages 1280-1283

  Vergouwen, M D I ^a,c   Frijns, C J M ^b   Roos, Y B W E M ^a   Rinkel, G J E ^b   Baas, F ^a   Vermeulen, M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Cerebral ischemia; Plasminogen activator inhibitor 1; Subarachnoid hemorrhage

Indexed keywords

ADULT; ALLELE; ANEURYSMAL SUBARACHNOID HEMORRHAGE; ARTICLE; BLEEDING; BRAIN ARTERY ANEURYSM RUPTURE; BRAIN ISCHEMIA; CONTROLLED STUDY; DISEASE CLASSIFICATION; DNA DETERMINATION; FEMALE; FIBRINOLYSIS; GENE; GENETIC POLYMORPHISM; GENOTYPE; GLASGOW COMA SCALE; HOMOZYGOSITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MICROTHROMBUS; NETHERLANDS; OUTCOMES RESEARCH; PLASMINOGEN ACTIVATOR INHIBITOR 1 GENE; PRIORITY JOURNAL; PROMOTER REGION; SUBARACHNOID HEMORRHAGE;

ALLELES; BRAIN ISCHEMIA; FEMALE; HUMANS; INTRACRANIAL ANEURYSM; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, GENETIC; PROGNOSIS; PROMOTER REGIONS (GENETICS); RECURRENCE; SUBARACHNOID HEMORRHAGE;

EID: 2542607777     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000128707.48644.7e     Document Type: Article

References (16)

1. Menges T, Hermans PW, Little SG, Langefeld T, Boning O, Engel J, Sluijter M, de Groot R, Hempelmann G. Plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism and prognosis of severely injured patients. Lancet. 2001;357:1096-1097.
2. Hermans PW, Hibberd ML, Booy R, Daramola O, Hazelzet JA, de Groot R, Levin M. 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Meningococcal Research Group. Lancet. 1999;354:556-560.
3. Westendorp RG, Hottenga JJ, Slagboom PE. Variation in plasminogen-activator inhibitor-1 gene and risk of meningococcal septic shock. Lancet. 1999;354:561-563.
4. Yamada N, Arinami T, Yamakawa-Kobayashi K, Watanabe H, Sohda S, Hamada H, Kubo T, Hamaguchi H. The 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene is associated with severe pre-eclampsia. J Hum Genet. 2000;45:138-141.
5. Mohanty D, Ghosh K, Nandwani SK, Shetty S, Phillips C, Rizvi S, Parmar BD. Fibrinolysis, inhibitors of blood coagulation, and monocyte derived coagulant activity in acute malaria. Am J Hematol. 1997;54: 23-29.
6. Aoki K, Aikawa N, Sekine K, Yamazaki M, Mimura T, Urano T, Takada A. Elevation of plasma free PAI-1 levels as an integrated endothelial response to severe bums. Burns. 2001;27:569-575.
7. Roos Y, Rinkel GJE, Algra A, van Gijn J, Vermeulen M. Systematic review of antifibrinolytic treatment in aneurysmal subarachnoid hemorrhage. J Neurol Neurosurg Psychiatry. 1998;65:942-943.
8. Roos Y, for the STAR-Study Group. Antifibrinolytic treatment in aneurysmal subarachnoid haemorrhage: a randomised placebo-controlled trial. Neurology. 2000;54:77-82.
9. Hillman J, Fridriksson S, Nilsson O, Yu Z, Saveland H, Jakobsson KE. Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study. J Neurosurg. 2002;97:771-778.
10. Roos YBWEM, Levi M, Carroll TA, Beenen LFM, Vermeulen M. Nimodipine increases fibrinolytic activity in patients with aneurysmal subarachnoid hemorrhage. Stroke. 2001;32:1860-1862.
11. Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974;:2:81-84.
12. Jennett B, Bond M. Assessment of outcome after severe brain damage Lancet. 1975;1:480-484.
13. Matsubara Y, Murata M, Isshiki I, Watanabe R, Zama T, Watanabe G, Watanabe K, Ikeda Y. Genotype frequency of plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism in healthy Japanese males and its relation to PAI-1 levels. Int J Hematol. 1999;69:43-47.
14. Margaglione M, Grandone E, Vecchione G, Cappucci G, Giuliani N, Colaizzo D, Celentano E, Panico S, Di Minno G. Plasminogen activator inhibitor-1 (PAI-1) antigen plasma levels in subjects attending a metabolic ward: relation to polymorphisms of PAI-1 and angiotensin converting enzyme (ACE) genes. Arterioscler Thromb Vasc Biol. 1997;17: 2082-2087.
15. Brouwers PJ, Dippel DW, Vermeulen M, Lindsay KW, Hasan D, van Gijn J. Amount of blood on computed tomography as an independent predictor after aneurysm rupture. Stroke. 1993;24:809-814.
16. Pickard JD, Murray GD, Illingworth R, Shaw MD, Teasdale GM, Foy PM, Humphrey PR, Lang DA, Nelson R, Richards P, Sinar J, Bailey S, Skene A. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British Aneurysm Nimodipine Trial. BMJ. 1989;298:636-642.